Submit the keyword or topic you are searching for

  1. Home
  2. Health
  3. Aclaris stock rallies 53% amid licensing deal, Piper upgrade
Health

Aclaris stock rallies 53% amid licensing deal, Piper upgrade

featured-image

sutthirat sutthisumdang Shares of Aclaris Therapeutics ( NASDAQ: ACRS ) rallied 53% Monday after the company announced it had exclusively licensed two immunology drug candidates from Biosion, prompting an upgrade by Piper Sandler. Early Monday, Aclaris ( ACRS ) said it had entered into an exclusive.

My Protein Germany

Myprotein UK

Menkind UK

Top News

Storm Bert tracker LIVE: Met Office weather warnings as 70mph winds to batter Britain

Storm Bert, the second storm of the year, will hit the UK to...

Ukraine says new missile fired by Russia flew for 15 minutes, faster than Mach 11

Galloway Hoard to go on display in Australia at start of international tour

Israel army says killed five Hamas militants in north Gaza raid

Related Posts

post-thumbnail
Health

How To Prevent Pancreatic Cancer? Early Detection and Genetic Risks Key to Better Outcomes

post-thumbnail
Health

Amneal files again for FDA approval of first dihydroergotamine autoinjector

post-thumbnail
Health

Short-term menopausal hormone therapy shows no long-term cognitive effects

post-thumbnail
Health

Restaurant review: I didn’t think a beer-paired dinner was for me – but this tasting menu is a triumph

post-thumbnail
Health

Need extra support? Get 30% off Brooklyn Bedding's Titan Plus mattress in huge Black Friday sale

post-thumbnail
Health

Senior managers at Hong Kong public hospitals may be held responsible for blunders

post-thumbnail
Health

Cetuximab performs better than durvalumab in treating head and neck cancers

post-thumbnail
Health

Natural, Scientifically Supported Dandruff Treatments